Galectin-3 as a cardiac biomarker has proven to be a significant prognostic tool in adults.
However, it has not yet been established in the pediatric population as a biomarker in daily …

Durable and temporary mechanical circulatory support (MCS) use is growing for a range of
cardiovascular indications. Kidney dysfunction is common in people evaluated for or …

Introduction: Acute kidney injury is a risk factor for chronic kidney disease and mortality after
congenital heart surgery under cardiopulmonary bypass. The neutrophil–lymphocyte ratio is …

Background and Objectives: By definition, acute kidney injury (AKI) is a clinical syndrome
diagnosed when the increase in serum creatinine concentration is> 0.3 mg/dL in 48 h or> …

Background Prolonged hospital length of stay after congenital heart surgery is a significant
cost burden and is associated with postoperative morbidity. Our goal was to evaluate the …

Aim Cardiac biomarkers' predictive value of contrast‐associated acute kidney injury (CA‐
AKI) remains unclear. We analysed whether creatine kinase isoenzyme‐MB (CKMB) …

Galectin-3 (Gal-3) is a novel pro-fibrotic biomarker that can predict both right and left cardiac
dysfunction caused by various cardiovascular conditions. Its expression seems to be …

Objective Serum N-terminal pro-B-type natriuretic peptide (NT-proBNP) and cystatin C
(sCysC) are available clinically and beneficial in diagnosing acute kidney injury (AKI). Our …

Introduction: The ongoing COVID-19 pandemic is placing an extraordinary burden on our
health care system with its limited resources. Accurate triage of patients is necessary to …

Background Acute kidney injury (AKI) significantly increases morbidity and mortality
following cardiac surgery, especially in patients with pre-existing renal impairments. N …